MedPath

Repeated IPCischemic preconditioning, RIPC, ischemic reperfusion injury, endothelial function, end-stage renal disease, flow-mediated dilation (FMD)ischemisch preconditioneren (IPC), herhaalde IPC, ischemisch reperfusie schade, endotheel functie, flow-gemedieerde dilatatie

Recruiting
Registration Number
NL-OMON29689
Lead Sponsor
Radboudumc Nijmegen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

Informed consent

Age > 18 years

Exclusion Criteria

-The presence of a patent arterio-venous fistula (for dialysis)

-Peripheral artery occlusive disease stage III and IV. Poor peripheral skin vascular can interfere with performance of superficial femoral artery measurements

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Brachial artery endothelial function (measured as flow-mediated dilation)
Secondary Outcome Measures
NameTimeMethod
To examine the effect of daily repeated ischemic preconditioning arm on superficial femoral artery function (measured as FMD%) during 7 days in patients with chronic kidney disease.<br><br /><br /><br>To examine the effect of daily repeated ischemic preconditioning on ex vivo innate immune responses
Ā© Copyright 2025. All Rights Reserved by MedPath